Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market

LONDON -

The medical device industry is one of the most vital and dynamic sectors of the European economy. The industry is constantly driven by R&D, which needs to keep pace with the evolving demands of the medical fraternity.

(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (www.medicaldevices.frost.com), European Medical Device Company Profiles, finds that the global medical device market comprises three main regions - the United States, Europe and Japan. The United States represents the largest share with approximately 40 per cent, followed by the European Union (EU) countries with 30 per cent and rest of the world with 30 per cent. The following segments are covered in the research: anaesthetic and respiratory devices, cardiology and thoracic surgery devices, minimally invasive surgical devices, neurology and neuromuscular devices, ophthalmic and optical devices, orthopaedic and prosthetic devices, single-use surgical and disposables and wound care/management and biomaterials.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brochure will be sent to you by e-mail.

A number of large international companies are active in the field of medical device manufacturing. Some, among these, are taking a leading position in the European market.

“The European medical device market is highly fragmented, with numerous niche product lines representing modest market sizes,” states Frost & Sullivan Research Associate Sree Vidhya Praveen. “Companies involved in medical device manufacturing range from large corporations producing a broad range of devices and pursuing a global marketing strategy on a worldwide scale to small and medium companies concentrating on a single product line or on a specific geographic region.”

The major competitors to European medical device manufacturers are traditionally from the United States and Japan. However, European manufacturers have a strong position in Europe, where approximately 78 per cent of the products sold are manufactured within the EU.

Despite the gloomy economic trends, most medical device companies reported positive domestic and international sales growth and continued optimism about prospects for the industry in 2009. Now that the meltdown is fading, most medical-device manufacturers are divulging their adaptation in times of rough weather.

Manufacturers were capable of quickly adapting to market trends and were able to achieve greater profit margins. Emerging markets in Asia, Eastern Europe and Latin America constituted areas of potential growth for these European producers.

“Innovative and cost-effective products are likely to constitute the key elements of success in the future,” says Vidhya. “The extent to which European producers continue to compete depends on their willingness to engage in product differentiation, increased R&D expenditure and a coordinated research and development policy with governing authorities.”

European Medical Device Company Profiles is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: European Bone Growth and Spinal Fusion Stimulators Market, European Tissue Sealants and Topical Hemostats Market and European Market for Biopsy Devices. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit www.frost.com.

European Medical Device Company Profiles M368 Contact: Katja Feick Corporate Communications - Europe P: +49-(0)-69-7703343 E: katja.feick@frost.com

www.frost.com

Source: Frost & Sullivan

Katja Feick, Corporate Communications - Europe, Frost & Sullivan, +49-(0)-69-7703343, katja.feick at frost.com ; Photo: https://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO